These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Two galactomannans and scleroglucan as matrices for drug delivery: preparation and release studies. Coviello T, Alhaique F, Dorigo A, Matricardi P, Grassi M. Eur J Pharm Biopharm; 2007 May; 66(2):200-9. PubMed ID: 17156985 [Abstract] [Full Text] [Related]
23. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation. Nabais T, Brouillet F, Kyriacos S, Mroueh M, Amores da Silva P, Bataille B, Chebli C, Cartilier L. Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270 [Abstract] [Full Text] [Related]
24. [Comparative study of sustained-release in theophylline (Slobid, Theolong, Theodur) by pharmacokinetics]. Kotake T, Mihara M, Shibakawa M, Asamoto. Arerugi; 1997 Apr; 46(4):370-5. PubMed ID: 9154697 [Abstract] [Full Text] [Related]
26. In vivo evaluation of a theophylline oral controlled-release unit dosage form. Gangadharan B, Ritschel WA, Hussain SA. Arzneimittelforschung; 1987 Nov; 37(11):1256-7. PubMed ID: 3440033 [Abstract] [Full Text] [Related]
27. Scleroglucan sustained-release oral preparations. Part I. In vitro experiments. Touitou E, Alhaique F, Riccieri FM, Riccioni G, Santucci E. Drug Des Deliv; 1989 Dec; 5(2):141-8. PubMed ID: 2577984 [Abstract] [Full Text] [Related]
29. Development and evaluation of matrix and two layered sustained release suppositories of theophylline. Maity S, Sa B, Bandyopadhyay AK. Boll Chim Farm; 2001 Dec; 140(6):462-6. PubMed ID: 11822240 [Abstract] [Full Text] [Related]
30. Application of fibroin in controlled release tablets containing theophylline. Katayama H, Issiki M, Yoshitomi H. Biol Pharm Bull; 2000 Oct; 23(10):1229-34. PubMed ID: 11041257 [Abstract] [Full Text] [Related]
31. Development of sustained release gastroretentive drug delivery system for ofloxacin: in vitro and in vivo evaluation. Chavanpatil M, Jain P, Chaudhari S, Shear R, Vavia P. Int J Pharm; 2005 Nov 04; 304(1-2):178-84. PubMed ID: 16198522 [Abstract] [Full Text] [Related]
32. In vitro dissolution kinetic study of theophylline from hydrophilic and hydrophobic matrices. Maswadeh HM, Semreen MH, Abdulhalim AA. Acta Pol Pharm; 2006 Nov 04; 63(1):63-7. PubMed ID: 17515331 [Abstract] [Full Text] [Related]
33. Time-controlled pulse-drug release from dry-coated wax matrix tablets for colon drug delivery. Peerapattana J, Otsuka K, Otsuka M. Biomed Mater Eng; 2004 Nov 04; 14(3):293-301. PubMed ID: 15299241 [Abstract] [Full Text] [Related]
34. Compression coated systems for colonic delivery of 5-fluorouracil. Sinha VR, Singh A, Singh S, Bhinge JR. J Pharm Pharmacol; 2007 Mar 04; 59(3):359-65. PubMed ID: 17331338 [Abstract] [Full Text] [Related]
36. Study of the critical points of HPMC hydrophilic matrices for controlled drug delivery. Miranda A, Millán M, Caraballo I. Int J Pharm; 2006 Mar 27; 311(1-2):75-81. PubMed ID: 16446063 [Abstract] [Full Text] [Related]
37. In vitro and in vivo evaluation of guar gum-based matrix tablets of rofecoxib for colonic drug delivery. Al-Saidan SM, Krishnaiah YS, Satyanarayana V, Rao GS. Curr Drug Deliv; 2005 Apr 27; 2(2):155-63. PubMed ID: 16305416 [Abstract] [Full Text] [Related]
39. Development and evaluation of pulsatile drug delivery system using novel polymer. Tekade AR, Gattani SG. Pharm Dev Technol; 2009 Apr 27; 14(4):380-7. PubMed ID: 19235549 [Abstract] [Full Text] [Related]
40. Effect of channeling agents on the release pattern of theophylline from kollidon SR based matrix tablets. Ibn Razzak MS, Khan F, Hossain M, Khan MZ, Azad MA, Reza MS. Pak J Pharm Sci; 2009 Jul 27; 22(3):303-7. PubMed ID: 19553179 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]